Inhalation Flow Rate-study

NCT02563197 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchiectasis

Interventions

DEVICE: T-326 Inhaler

Sponsor

Bayer

Collaborators

[object Object]